Team Tony Cancer Foundation, Inc. – Trademark Portfolio
Entity Type: 03
Team Tony Cancer Foundation, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 36 (Insurance & Financial) — 4 filings in this category. The portfolio also extends into Class 41 (Education & Entertainment) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include TEAM TONY and GRAN FONDO SARASOTA. The owner is based in Sarasota, FL.
3562 South Osprey Avenue Ste. C
Sarasota, FL 34239
Showing of trademarks Trademarks
Trademark Classifications
Team Tony Cancer Foundation, Inc.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does Team Tony Cancer Foundation, Inc. have?
Team Tony Cancer Foundation, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 2 registered, 3 cancelled.
What trademark classes does Team Tony Cancer Foundation, Inc. file in?
Team Tony Cancer Foundation, Inc. files trademarks across 2 Nice Classification classes. The most active classes are Class 36 (Insurance & Financial), Class 41 (Education & Entertainment). Class 36 covers insurance; financial affairs; monetary affairs; real estate affairs.
What are Team Tony Cancer Foundation, Inc.'s most well-known trademarks?
Team Tony Cancer Foundation, Inc.'s registered trademark portfolio includes well-known marks such as TEAM TONY and GRAN FONDO SARASOTA. These are among 2 currently registered trademarks in the portfolio.
What is Team Tony Cancer Foundation, Inc.'s trademark registration success rate?
Team Tony Cancer Foundation, Inc. has a 40% trademark registration rate, with 2 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.